Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > Updated Corporate Presentation - April 2022
View:
Post by LOOPA441 on Apr 15, 2022 12:41am

Updated Corporate Presentation - April 2022

No timelines provided.
No mention of Janssen.
Beta-amyloid slide on page 7 looks new.
Competitors on page 8 looks revised.

Can someone with the previous version please confirm changes.

Show me the money.

https://www.bioasis.us/investors/
Comment by KayakerBC on Apr 15, 2022 10:45am
I don't have the September 2021 presentation, so dunno about page 7 (beta-amyloid).  Page 8 (competitors) is identical to what was in the March 2021 presentation.
Comment by Finallytherock on Apr 15, 2022 12:16pm
lol, as expected, nothing going on. timelines set just seem to go by 
Comment by MineDigger on Apr 19, 2022 6:14am
Using the free online comparator draftable.com and the September 2021 CP as the reference the main changes seen in their side-by-side comparison are: No Pipeline summary Slide 4 No Patnering Slide 6 No Superior to Transferrin Slide 9 but is replaced with a different chart No Chiesi Slide 13 ... and through to 19 missing too New Slide 14 lists Patent Protection New Slide 15 lists ...more  
biOasis Technologies Ord Shs
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities